Abbott Laboratories Investigates Two Cyber Incidents, Reports No Operational Impact

Abbott Laboratories (NYSE: ABT) announced on Friday it is investigating two separate cybersecurity incidents involving unauthorized access to its systems. The medical device manufacturer stated that its core operations have not been affected and it does not anticipate a material impact on its business or financial results.

Details of the Breaches

According to the company, the first incident involved unauthorized access to some internal systems within its cancer diagnostics business. Abbott specified that these were legacy Exact Sciences systems, which are maintained separately from Abbott's primary corporate network. The company noted that no other business units, sites, or systems were impacted.

The second incident involved an alleged breach of the LabCentral portal, a third-party-hosted platform used by Abbott’s core laboratory diagnostics business. Abbott clarified that this portal contains publicly available technical product documents, such as operating manuals and product specifications, and does not house proprietary or sensitive customer or business information.

Ad

Company Response and Market Context

Abbott has taken steps to address the situations, including engaging external cybersecurity experts and notifying law enforcement. The company's investigation into what specific information may have been accessed is ongoing. As of the announcement, Abbott reported no known exposure of sensitive customer or business data from either incident.

The healthcare sector has become an increasingly frequent target for cyberattacks. This event follows recent security incidents reported by other major industry players, including Medtronic, Stryker, and Novo Nordisk, highlighting the persistent digital security challenges facing the industry.